Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months
- 1 October 1999
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 34 (4) , 1153-1158
- https://doi.org/10.1016/s0735-1097(99)00321-6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- An Assessment of Heart-Valve Abnormalities in Obese Patients Taking Dexfenfluramine, Sustained-Release Dexfenfluramine, or PlaceboNew England Journal of Medicine, 1998
- The Prevalence of Cardiac Valvular Insufficiency Assessed by Transthoracic Echocardiography in Obese Patients Treated with Appetite-Suppressant DrugsNew England Journal of Medicine, 1998
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Carcinoid Heart DiseaseCirculation, 1995
- Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.Circulation, 1993
- Valve Disease Associated with Ergot Alkaloid Use: Echocardiographic and Pathologic CorrelationsAnnals of Internal Medicine, 1992
- Long-term weight control study: ConclusionsClinical Pharmacology & Therapeutics, 1992
- Age-related Prevalence of Valvular Regurgitation in Normal Subjects: A Comprehensive Color Flow Examination of 118, VolunteersJournal of the American Society of Echocardiography, 1990
- Evaluation of aortic insufficiency by Doppler color flow mappingJournal of the American College of Cardiology, 1987
- Color Doppler assessment of mitral regurgitation with orthogonal planes.Circulation, 1987